Pharmaceutical Law & Regulatory Counsel
Lanton, Lanton & Sosa Law PLLC advises pharmaceutical manufacturers, emerging drug companies, distributors and commercial teams on U.S. healthcare law and the contracts that govern commercialization. With offices in Boston and Washington, D.C., we work with executives and legal departments on individual projects and ongoing matters.
Legal Services for Pharmaceutical Companies
Commercial agreements: Negotiation and review of distribution, supply, vendor, services and strategic partnership agreements, including allocation of regulatory responsibilities and commercial risk.
Healthcare regulatory counsel: Analysis of federal and state healthcare requirements affecting product distribution, commercial relationships and market entry.
Pricing, reimbursement and market access: Legal analysis of government reimbursement policies, payer and channel arrangements, and the implications of drug pricing legislation.
340B and pharmacy distribution: Counsel on 340B program requirements, manufacturer and contract pharmacy arrangements, specialty pharmacy relationships and pharmacy regulation.
U.S. market entry: Legal and contractual support for international manufacturers establishing U.S. operations or negotiating domestic commercial partnerships.
Government affairs: Legislative and regulatory representation on policy affecting pharmaceutical commercialization, reimbursement and distribution.
Working With Pharmaceutical Legal Teams
We serve as outside general counsel or work with in-house counsel and other law firms on discrete regulatory and commercial matters, subject to conflicts review. International business advisory services are provided separately through Lanton Strategies International B.V.
Visit our Insights for analysis of pharmaceutical legal and policy developments. Contact LL&S to discuss your company’s legal needs.